Authors: | Modak, S.; Cheung, I. Y.; Kushner, B. H.; Kramer, K.; Reich, L.; Cheung, N. K. V. |
Article Title: | Plerixafor plus granulocyte-colony stimulating factor for autologous hematopoietic stem cell mobilization in patients with metastatic neuroblastoma |
Abstract: | Current therapies for high-risk neuroblastoma (NB) necessitate the availability of several aliquots of autologous peripheral blood stem cells to reverse-associated myelosuppression. Priming with the CXCR4 inhibitor plerixafor plus G-CSF was associated with successful stem cell harvest in 5/7 heavily prior-treated patients with stage 4 NB who had previously failed G-CSF priming. Minimal residual disease was not detected in harvested cells from any patient despite the presence of disease in bone/bone marrow in 6/7. Hematopoietic reconstitution was achieved in all three patients receiving plerixafor-primed stem cells after myeloablative therapy. Plerixafor is an effective and safe agent for stem cell collection in patients with NB. Ā© 2011 Wiley Periodicals, Inc. |
Keywords: | adolescent; adult; child; clinical article; treatment outcome; child, preschool; retrospective studies; drug efficacy; drug safety; drug therapy, combination; neuroblastoma; stem cell mobilization; granulocyte colony stimulating factor; granulocyte colony-stimulating factor; plerixafor; hematopoietic stem cell mobilization; heterocyclic compounds; autologous hematopoietic stem cell transplantation; receptors, cxcr4 |
Journal Title: | Pediatric Blood and Cancer |
Volume: | 58 |
Issue: | 3 |
ISSN: | 1545-5009 |
Publisher: | Wiley Periodicals, Inc |
Date Published: | 2012-03-01 |
Start Page: | 469 |
End Page: | 471 |
Language: | English |
DOI: | 10.1002/pbc.23132 |
PUBMED: | 21416584 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | --- - "Cited By (since 1996): 1" - "Export Date: 7 May 2012" - "CODEN: PBCEA" - "Source: Scopus" |